IAIM
ZVRA icon

International Assets Investment Management’s Zevra Therapeutics ZVRA Stock Holding History

International Assets Investment Management’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6,940
Closed -$1K – 2008
2024
Q3 		$1K Buy
6,940
+5,940
+594% +$40.3K ﹤0.01% 1122
2024
Q2 		$4.9K Buy
+1,000
New +$4.74K ﹤0.01% 1852
2023
Q2 		– Sell
-1,000
Closed -$5.5K – 1193
2023
Q1 		$5.5K Buy
+1,000
New +$5.29K ﹤0.01% 902

Other funds holding ZVRA

WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

International Assets Investment Management's ZVRA Position: Q4 2024 in Review

International Assets Investment Management sold out of Zevra Therapeutics (ZVRA) in Q4 2024, closing a stake of 6,940 shares — an estimated $1K sold.

International Assets Investment Management first reported a position in ZVRA in Q1 2023 and held it in 3 quarters. The position peaked at $5.5K in Q1 2023. 109 funds tracked by Wall St. Rank hold ZVRA as of Q4 2024.

  • International Assets Investment Management reported no remaining Zevra Therapeutics position as of Q4 2024 after selling out during the quarter.
  • International Assets Investment Management sold 6,940 Zevra Therapeutics shares in Q4 2024, an estimated $1K.
  • International Assets Investment Management first reported a position in Zevra Therapeutics in Q1 2023 and held it in 3 quarters.
  • International Assets Investment Management's Zevra Therapeutics position peaked at $5.5K in Q1 2023.
  • 109 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q4 2024.

Based on International Assets Investment Management's 13F filing for Q4 2024, filed 8 Jan 2025.